Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of Treatment With Lenalidomide Plus R-CHOP21 (LR-CHOP21) for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (DLBCL).
Phase of Trial: Phase I/II
Latest Information Update: 22 May 2014
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 22 May 2014 Status changed from active, no longer recruiting to completed, based on publication of results.
- 12 May 2014 Results published in the Lancet Oncology.
- 10 Dec 2013 Final results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.